Basit öğe kaydını göster

dc.contributor.authorBalci, Huriye
dc.contributor.authorSeymen, Hakki Oktay
dc.contributor.authorAytac, Erman
dc.contributor.authorSuzer, Oner
dc.contributor.authorUzun, Hafize
dc.contributor.authorDedeoglu, Burcak Deniz
dc.contributor.authorSeymen, Pinar
dc.date.accessioned2021-03-04T13:40:13Z
dc.date.available2021-03-04T13:40:13Z
dc.date.issued2008
dc.identifier.citationDedeoglu B. D. , Aytac E., Suzer O., Balci H., Uzun H., Seymen P., Seymen H. O. , "Donor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, cilt.78, sa.6, ss.415-421, 2008
dc.identifier.issn0952-3278
dc.identifier.othervv_1032021
dc.identifier.otherav_7da2367b-dea0-4d78-abbb-325351b5478f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/85827
dc.identifier.urihttps://doi.org/10.1016/j.plefa.2008.05.004
dc.description.abstractThis study was designed to assess the influence of St. Thomas Hospital cardioplegic solution (St. Th.) on heart preservation in rat hearts subjected to 6 h ischemia when supplemented with iloprost. In the control group (n = 8), nothing was added to St. Th., whereas 10 or 1000 nmol L(-1) iloprost was added in the second (n = 7) and third (n = 8) groups, respectively. Mechanical contraction parameters, cardiac tissue damage and oxidative stress markers were evaluated. The 10 nmol/L iloprost group peak systolic pressure (71.0+/-30.9 versus 41.0+/-9.4 mm Hg) and -dp/dt(max) (1103.8+/-94.3 versus 678.6+/-156.8 mm Hg s(-1)) were significantly higher than control group at 30 min of reperfusion (p<0.05). Iloprost supplemented groups had higher GSH and catalase levels of coronary perfusate at reperfusion, in comparison with initial values (p < 0.05). AST, CK, CK-MB values increased at 0 min of reperfusion and cTnI values at 45 min of reperfusion (p<0.05) in all groups with no difference between groups. According to our results, iloprost supplementation had mild but significant improvement in postischemic values in mechanical and oxidative stress parameters, resulting in better heart preservation. (C) 2008 Elsevier Ltd. All rights reserved.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectHistoloji-Embriyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectHÜCRE BİYOLOJİSİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.titleDonor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts
dc.typeMakale
dc.relation.journalPROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume78
dc.identifier.issue6
dc.identifier.startpage415
dc.identifier.endpage421
dc.contributor.firstauthorID18772


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster